Navigation LinksBiology NewsHealth NewsBiology TechnologyMedicine Technology


Helix Biopharma to Present L-DOS47 Lung Cancer Research Findings at the Fourth International Conference on Tumor Microenvironment in Florence, Italy

- Helix BioPharma Corp. (TSX: HBP /Frankfurt: WKN918864) AURORA, ON, March 5 /CNW/Dr. Heman Chao, Vice President of Researchat Helix BioPharma Corp., a developer of novel cancer therapeutics,will be presenting a scientific poster at the Fourth InternationalConference on Tumor Microenvironment, which runs from March 6th to10th in Florence, Italy. The conference, hosted by the...

Replidyne Phase II Pediatric Trial Meets Primary Objective

LOUISVILLE, Colo., March 06, 2007 /PRNewswire-FirstCall/ --Replidyne, Inc. announced today that it has completed its Phase IIclinical trial using faropenem medoxomil (faropenem) in pediatricpatients with acute otitis media (AOM), a common infection of themiddle ear. Initial analyses of the study results show that it metits primary objective to show that faropenem was effective ineradicatin...

DVT Awareness Survey Findings: Heart and Respiratory Patients

WASHINGTON, March 06, 2007 /PRNewswire/ -- Up to two millionAmericans are affected each year by DVT, with up to 600,000hospitalized. Its primary complication, pulmonary embolism (PE),claims up to 300,000 lives annually -- more than breast cancer andAIDS combined. People who suffer from cardiovascular disease may beat increased risk for DVT, because these factors also heighten thelikelihood...

Pozen Announces Positive Outcome for PA 325

Chapel Hill, N.C., March 6, 2007-Pozen Inc. (NASDAQ: POZN),today announced top-line results of its "Safer Aspirin" PA 325proof-of-concept study conducted during the fourth quarter of 2006.PA 325 is a patented formulation of 325mg of aspirin surrounded bya 20mg coating of an immediate release formulation of a proton pumpinhibitor. The PA 325, 28 day study, involved two groups of 40 subject...

Advanced Magnetics Announces Presentation of Ferumoxytol Data at the National Kidney Foundation 2007 Spring Clinical Meetings

CAMBRIDGE, Mass., March 06, 2007 /PRNewswire-FirstCall/ --Advanced Magnetics today announced that data from three completedPhase III multi- center clinical studies of ferumoxytol as anintravenous iron replacement therapeutic will be presented duringthe National Kidney Foundation (NKF) 2007 Spring Clinical Meetingstaking place April 10th through 14th in Orlando, Florida. Twoposters containi...

POZEN Announces Positive Outcome for PA 325 Proof of Concept Study

CHAPEL HILL, N.C.--(BUSINESS WIRE)--Mar 6, 2007 - POZEN Inc.(NASDAQ: POZN), today announced top-line results of its "SaferAspirin" PA 325 proof-of-concept study conducted during the fourthquarter of 2006. PA 325 is a patented formulation of 325mg ofaspirin surrounded by a 20mg coating of an immediate releaseformulation of a proton pump inhibitor. The PA 325, 28 day study, involved two group...

Nventa Announces Presentation of Positive HspE7 Data from NCI-Sponsored Clinical Trial in Cervical Dysplasia

- 78 Percent of Patients Showed Complete Response or Reduction ofLesion Size by More than Fifty Percent - SAN DIEGO, CA, March 05, 2007 /PRNewswire-FirstCall/ - NventaBiopharmaceuticals Corporation today announced the presentation ofpositive results from a clinical trial examining the safety andefficacy of pilot process HspE7, an investigational therapeuticvaccine for human papillomavirus (...

AOP Orphan Pharmaceuticals and Lantibio Announce Positive Phase II Study with Novel Cystic Fibrosis Therapy

VIENNA, Austria and CHAPEL HILL, N.C., US, March 06, 2007/PRNewswire/ -- AOP Orphan Pharmaceuticals AG ("AOP Orphan") andLantibio, Inc. ("Lantibio") today announced positive final resultsfrom their placebo controlled, double-blinded Phase II clinicalstudy of Moli1901, an experimental compound to treat cysticfibrosis ("CF"). Moli1901 is being developed by AOP Orphan inEurope under a licensi...

Advanced Cell Technology's Ability to Rescue Vision in Blind Rats Noted in Scientific American

ALAMEDA, Calif.--(BUSINESS WIRE)--Mar 5, 2007 - Advanced CellTechnology, Inc.'s (OTCBB: ACTC) ability to rescue vision in blindrats was noted in Scientific American's March 2007 issue as thelead story of its News Scan section. The full text of the article,which notes Advanced Cell's ability to "coax embryonic stem cellsto turn into transplantable retinal pigment epithelial (RPE)tissue," is...

Accentia Biopharmaceuticals Scientific Presentations Demonstrate Increasing Acceptance of Fungal Etiology of Chronic Sinusitis at the Annual Meeting of the American Academy of Allergy, Asthma, and Immunology

TAMPA, Fla.--(BUSINESS WIRE)--Mar 7, 2007 - AccentiaBiopharmaceuticals, Inc. (NASDAQ: ABPI), presented three posters atthe Annual Meeting of the American Academy of Allergy, Asthma, andImmunology from February 23 - 27, 2007 in San Diego, CA. Theposters discussed findings from a survey of 202 otolaryngologists(ENTs) and allergists in the U.S., U.K., France, and Germany on theburden of chroni...
[next]
(Date:4/17/2019)... ... April 17, 2019 , ... The IBS ... initiative this April to designate April 19th as World IBS Day to raise ... & healthcare professionals in their pursuit to find treatments. Irritable Bowel Syndrome is ...
(Date:4/17/2019)... ... 2019 , ... On May 3, Kyle Marcelli will return to Mid-Ohio ... IMSA Continental Tire SportsCar Challenge race in 2018, Kyle Marcelli and ... their #60 KohR Motorsports / Roush Performance Ford Mustang GT4 across the ...
(Date:4/17/2019)... (PRWEB) , ... April 17, 2019 , ... Signaled.online is ... are available for users: alarm, monitoring of the web resources and reminder. , The ... well as if you live alone. If you haven’t logged in to the website ...
(Date:4/17/2019)... ... April 17, 2019 , ... Tune in Wednesday, April ... Excellence who overcame infertility and endometriosis with robotic surgery. Hosts Dr. Jonathan Zaidan, ... robotic surgery for patients and the impact robotic surgery can have on a woman’s ...
(Date:4/17/2019)... LAUDERDALE, Fla. (PRWEB) , ... April 17, 2019 ... ... of top-quality chiropractic care in South Florida, is proud to sponsor the 25th ... Coalition (GCACC). , “As a local chiropractic practice, we are proud to ...
Breaking Medicine News(10 mins):
... free site where consumers can both rate a hospital or ... ... Pasadena, CA (PRWEB) March 3, 2009 -- RateYourHospitalStay.com, http://www.rateyourhospitalstay.com , is ... across the U.S. The site also allows people who have recently ...
... releases the first in a series of residential vacuum cleaner reviews ... , ... Boise, Idaho (Vocus) March 3, 2009 -- Before spending hundreds of ... the market, savvy shoppers turn to the Internet to research their choices. ...
... Bausch & Lomb, the global eye health company, has ... Ltd., for the development of certain intraocular lens (IOL) ... Lomb has obtained the rights to Santen,s hydrophobic acrylic ... sale worldwide. Santen reserves the right for the use ...
... Moresby, Papua New Guinea The southeast Pacific ... the most biologically diverse ecosystems on Earth, has created ... swath of pristine tropical forest larger than Singapore. , ... in concert with local communities neighboring the newly established ...
... New studies in the United States and Canada show that ... of new mothers about infant crying, the most common trigger ... mothers in Seattle is featured in the March issue of ... Columbia appears this month in The Canadian Medical Association ...
... the U.S. Government Accountability Office (GAO) Report on the ... Responsible Nutrition (CRN), the leading trade association representing the ... from Steve Mister, president and CEO, CRN: "As ... that this one demonstrates that the industry has come ...
Cached Medicine News:
Inquire...
Light Diagnostics Measles IgM Capture Enzyme Immunoassay kit is intended for in vitro diagnostic use for the qualitative confirmation of serum IgM to measles virus....
Measles IgM Enzyme-Linked Immunosorbent Assay (ELISA) is intended for the in vitro determination of Measles IgM antibodies in human serum. For in vitro diagnostic use. High complexity test....
The DSL-05-01-MEM Measles IgM Enzyme-Linked Immunosorbent Assay (ELISA) kit provides materials for the determination of IgM-class antibodies to Measles virus in human serum. This assay is intended fo...
Medicine Products:
(Date:4/18/2019)... ... 2019 , ... KVC Kentucky will host the 2nd Annual ... horse farm on May 17, 2019 to raise funds to support KVC Kentucky’s ... elegant venue highlights Kentucky's stunning farmland, prized Thoroughbred horses and beautiful equine architecture. ...
(Date:4/18/2019)... ... April 18, 2019 , ... ... announced the launch of its industry-leading OPTIMASE® portfolio of biobased enzymes for ... understand the unique needs and specific challenges faced by medical instrument cleaning ...
(Date:4/17/2019)... (PRWEB) , ... April 17, 2019 , ... Salt ... 2019 Honorary Doctorate recipients. They will receive their degrees at SLCC’s May 3 Commencement ... is the executive vice president over Corporate Affairs and Miller Family Philanthropy. Richards is ...
Breaking Medicine Technology:
... BioSurplus, Inc. today announced the appointment of Jackie ... oversee all sales and marketing activities, and focus ... business and service offerings. (Photo:   ... Townsend has over 25-years of experience ...
... WESTCHESTER, Ill., Nov. 15, 2010 ... radiosurgery for the treatment of cancer, advances in ... this summer,s 5th International Conference of the Novalis ... application of radiosurgery.   "Radiosurgery is ...
Cached Medicine Technology: